M. Villegas-Esguevillas Et Al. , "The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit," Biomedicine and Pharmacotherapy , vol.164, 2023
Villegas-Esguevillas, M. Et Al. 2023. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit. Biomedicine and Pharmacotherapy , vol.164 .
Villegas-Esguevillas, M., Cho, S., Vera-Zambrano, A., Kwon, J. W., Barreira, B., Telli, G., ... Navarro-Dorado, J.(2023). The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit. Biomedicine and Pharmacotherapy , vol.164.
Villegas-Esguevillas, Marta Et Al. "The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit," Biomedicine and Pharmacotherapy , vol.164, 2023
Villegas-Esguevillas, Marta Et Al. "The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit." Biomedicine and Pharmacotherapy , vol.164, 2023
Villegas-Esguevillas, M. Et Al. (2023) . "The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit." Biomedicine and Pharmacotherapy , vol.164.
@article{article, author={Marta Villegas-Esguevillas Et Al. }, title={The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit}, journal={Biomedicine and Pharmacotherapy}, year=2023}